Drug Detail

Drug Name Glesatinib
Trade Name
Synonyms MGCD265
Drug Descriptions

Glesatinib (MGCD265) inhibits several tyrosine kinases including MET, MST1R (RON), and AXL, as well as VEGFR1-3, and TIE2, which may result in decreased tumor growth (PMID: 25806189, PMID: 26555154).

DrugClasses AXL Inhibitor 24 MET Inhibitor 51 RON Inhibitor 10 VEGFR Inhibitor (Pan) 31


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Docetaxel + Glesatinib Docetaxel Glesatinib 1 1
Erlotinib + Glesatinib Erlotinib Glesatinib 3 1
Glesatinib Glesatinib 23 2
Glesatinib + Nivolumab Glesatinib Nivolumab 0 1

Additional content available in CKB BOOST